Right off the bat, the high-profile departure of Peter Marks, M.D., Ph.D., former director of the FDA’s Center for Biologics ...

Peter Marks’ ouster comes at a time when the sector is already suffering through a years-long public markets slump.

Dr. Peter Marks, director of the Center for Biologics Evaluation and Research at the FDA, resigns after being pressured by ...

The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...

Vaccine makers were hit particularly hard yesterday, as Marks’ resignation letter alluded to disagreements with HHS Secretary ...

The pharma industry, Wall Street and former government officials on Monday decried the forced resignation of FDA vaccine ...

In his resignation letter, Marks cited disagreement with HHS Secretary Robert F. Kennedy Jr., who he said pushed ...

Biotech stocks took a hit after the sudden resignation of Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

FDA vaccine official Dr. Peter Marks resigned amid reports he was forced out. In his letter, he condemned efforts to ...

The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center for ...

Peter Marks, the Food and Drug Administration (FDA) vaccine official who resigned last week amid pressure from the Trump administration, urged families to continue vaccinating their children.